According to the findings of a new Future Market Insights (FMI) report, the global Ibuprofen API Market crossed US$ 626.2 Million in 2022 and is expected to grow at a CAGR of 3% to reach US$ 772.2 Million by 2029. The key drivers of the Ibuprofen API market are the ongoing need for low-cost nonsteroidal anti-inflammatory medicines (NSAID) as well as the size and age of manufacturing facilities.
Increasing API drug shortages and the formation of a task force to address these issues, as well as the rise of cost-effective drug manufacturers in various countries and the supply of API drugs, mainly in developing nations, are all driving expansion in the ibuprofen API market.
The pharmaceutical API sector is experiencing a significant supply and demand constraint for Ibuprofen API, with major ibuprofen API producers halting output and a supply chain disruption in China exacerbated by decreased sales in India.
The volatility in Ibuprofen API is caused by factors such as a smaller number of competitors, a lower utilisation ratio, a lower margin level, new higher-value opportunities in complex combinations and high-grade API, the pace of FDA facility inspections, and ramping up production capacity through mergers and consolidation.
The global prevalence of a wide range of diseases, particularly cardiovascular disease, infectious diseases, diabetes, and kidney-related problems, is significant. As a result, the increasing frequency of a wide range of diseases among all age groups, as well as their global burden, pushes the demand for medication development and its market.
For better drug candidate identification, there has been an increase in the use of modern technologies such as high throughput, bioinformatics, and combinatorial chemistry. With increasing technologies, drug development has developed substantially, allowing the process to become more sophisticated, accurate, and time-consuming. High-throughput screening is one of the most extensively utilised drug discovery technologies due to automation, multi-detector readers, imaging gear, and software.
Leading Companies Profiled in Ibuprofen API Market are
BASF SE
BIOCAUSE Inc.
IOL Chemicals and Pharmaceuticals Limited
SI Group, Inc.
Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd.
Solara Active Pharma Sciences Limited
Granules India Limited
Read More@ https://www.futuremarketinsights.com/reports/ibuprofen-api-market
Key Segments of Ibuprofen API Industry Survey
Ibuprofen API Market by End User:
Contract Manufacturing Organizations
Pharmaceutical Companies